
A take-at-home tablet could boost the way cancer patients respond to chemotherapy, according to the medical experts who developed it.
The drug, known as KCL-HO-1i, works by disarming a defence mechanism that tumours use to protect themselves.

A take-at-home tablet could boost the way cancer patients respond to chemotherapy, according to the medical experts who developed it.
The drug, known as KCL-HO-1i, works by disarming a defence mechanism that tumours use to protect themselves.